Delivery Order SPE2DB22D1106-SPE2DB25FEYT4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.10 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, 30 grams, with a period of performance through November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.28, is for the delivery of Hydrocort-Pramoxine 1%-1% Cream (30g) and has an ultimate completion date of January 30, 2025. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. The contract is a firm-fixed-price delivery order,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Hydrocort-Pramoxine 1%-1% Cream, 30 grams, with a ceiling value of $1,724.46 and a completion date of April 15, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- This is a Delivery Order award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.56 firm fixed-price award is for the supply of a pharmaceutical product, Hydrocortisone-Pramoxine 2.5-1% Cream, 28.4 grams. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $170,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561526913 Hydrocort-Pramocaine 2.5-1% Cream 30gm. The single award delivery order was issued against an undisclosed governmentwide acquisition contract vehicle or blanket purchase agreement held by Amerisourcebergen. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work concluding by July 19, 2023. No subcontractors or set...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 453.6 grams of 1% hydrocortisone cream. The $1,219.04 order has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which does not have a set-aside designation. This delivery order is part of an indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,920.83, is for the delivery of 30-gram tubes of Hydrocortisone-Pramoxine 1%-1% cream. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization that is registered in the System for Award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $61,215.57, is for the delivery of Hydrocort-Pramoxine 2.5-1% cream, which is a pharmaceutical product used for medical treatment. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order. This contract is not associated with any set-aside designation, indicating that it was...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYT4Delivery Order
The Defense Logistics Agency awarded a $11,561.05 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in 30-gram containers. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. Through the SPE2DX prime contract vehicle, the company supplies a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities—to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. This delivery order for topical corticosteroid-local anesthetic cream fulfills routine pharmaceutical supply requirements within the broader defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 7/18/25 |